In terms of market side, this report researches the Oncology Drugs revenue, growth rate, market share by manufacturers, by type, by application and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
The global Oncology Drugs market size in 2023 is 164134.8 million US dollars, and it is expected to be 275873.9 million US dollars by 2030, with a compound annual growth rate of 7.7% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Oncology Drugs market include AbbVie, Inc., Amgen, Inc., Astellas Pharma, Inc., AstraZeneca PLC, and Bristol Myers Squibb Company. The share of the top 3 players in the Oncology Drugs market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Oncology Drugs market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Targeted Therapy accounted for XX% of Oncology Drugs market in 2023. Immunotherapy (Biologic Therapy) share of XX%.
Breast Cancer accounted for XX% of the Oncology Drugs market in 2023. Prostate Cancer accounts for XX%.
Report Includes:
This report presents an overview of global market for Oncology Drugs . Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key players of Oncology Drugs , also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Oncology Drugs , and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oncology Drugs market share and industry ranking of main players, data from 2019 to 2024. Identification of the major stakeholders in the global Oncology Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, from 2019 to 2030. Evaluation and forecast the market size for Oncology Drugs sales, projected growth trends, technology, application and end-user industry.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, economic analysis of global regions, and industry dynamic analysis, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapters 2-4: Segmented the global Oncology Drugs market by type, application and region. Analyze the revenue, sales and price of market segments from different perspectives.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Oncology Drugs market region sales and revenue data, and includes PEST Analysis.
Chapter 10: Analysis of the competitive environment of Oncology Drugs market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the players” M&A and New Entrants and Expansion Plans.
Chapter 11: Analyzes the main companies in the Oncology Drugs industry, including their main businesses, products/services, sales, prices, revenue, gross margin, and the latest developments.
Chapter 12: Analyzes the Oncology Drugs manufacturing cost, including raw material analysis, manufacturing cost structure, and industrial chain.
Chapter 13: Analyzes the Oncology Drugs industry chain, including marketing channels, distributors and major downstream buyers.
Chapters 14-16: Provide detailed Oncology Drugs market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 17: The main points and conclusions of the report.
Chapter 18: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Player list
AbbVie, Inc.
Amgen, Inc.
Astellas Pharma, Inc.
AstraZeneca PLC
Bristol Myers Squibb Company
F.Hoffmann-La Roche Ltd.
Johnson & Johnson
Novartis AG
Merck & Co., Inc.
Pfizer Inc.
Types list
Targeted Therapy
Immunotherapy (Biologic Therapy)
Chemotherapy
Hormonal Therapy
Application list
Breast Cancer
Prostate Cancer
Lung Cancer
Stomach Cancer
Colorectal Cancer
Liver Cancer
Esophagus Cancer
Cervical Cancer
Kidney Cancer
Bladder Cancer
Other Cancer
Table of Content
1 Oncology Drugs Market Introduction and Overview
1.1 Oncology Drugs Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Oncology Drugs Industry Dynamic Analysis
1.5.1 Oncology Drugs Market Trends Analysis
1.5.2 Oncology Drugs Market Drivers Analysis
1.5.3 Oncology Drugs Market Challenges Analysis
1.5.4 Oncology Drugs Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Oncology Drugs Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global Oncology Drugs Revenue and Share by Type
2.3 Global Oncology Drugs Sales and Share by Type
3 Global Oncology Drugs Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global Oncology Drugs Revenue and Share by Application (2019-2024)
3.3 Global Oncology Drugs Sales and Share by Application (2019-2024)
4 Global Market Growth Insights
4.1 Global Oncology Drugs Market Size (2019-2024)
4.2 Oncology Drugs Growth Insights by Regions
4.2.1 Oncology Drugs Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Oncology Drugs Revenue Market Size by Regions (2019-2024)
4.2.3 Oncology Drugs Sales Market Size by Regions (2019-2024)
4.2.4 North America Oncology Drugs Market Size (2019-2024)
4.2.5 Europe Oncology Drugs Market Size (2019-2024)
4.2.6 Asia-Pacific Oncology Drugs Market Size (2019-2024)
4.2.7 Latin America Oncology Drugs Market Size (2019-2024)
4.2.8 Middle East & Africa Oncology Drugs Market Size (2019-2024)
5 North America
5.1 North America Oncology Drugs Revenue by Countries
5.1.1 North America Oncology Drugs Revenue by Countries (2019-2024)
5.1.2 North America Oncology Drugs Sales by Countries (2019-2024)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific Oncology Drugs Revenue by Countries
6.1.1 Asia Pacific Oncology Drugs Revenue by Countries (2019-2024)
6.1.2 Asia Pacific Oncology Drugs Sales by Countries (2019-2024)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe Oncology Drugs Revenue by Countries
7.1.1 Europe Oncology Drugs Revenue by Countries (2019-2024)
7.1.2 Europe Oncology Drugs Sales by Countries (2019-2024)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America Oncology Drugs Revenue by Countries
8.1.1 Latin America Oncology Drugs Revenue by Countries (2019-2024)
8.1.2 Latin America Oncology Drugs Sales by Countries (2019-2024)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Oncology Drugs Revenue by Countries
9.1.1 Middle East & Africa Oncology Drugs Revenue by Countries (2019-2024)
9.1.2 Middle East & Africa Oncology Drugs Sales by Countries (2019-2024)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global Oncology Drugs Market Competition, by Players
10.1 Global Oncology Drugs Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Oncology Drugs Players Market Share in 2023
10.2.2 Top 6 Oncology Drugs Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Oncology Drugs Players Head Office, Business Provided
10.4 Oncology Drugs Mergers & Acquisitions
10.5 Oncology Drugs New Entrants and Expansion Plans
11 Players Profiles
11.1 AbbVie, Inc.
11.1.1 AbbVie, Inc. Company Profile
11.1.2 Oncology Drugs Product Overview
11.1.3 AbbVie, Inc. Oncology Drugs Market Performance (2019-2024)
11.1.4 AbbVie, Inc. Business Overview
11.1.5 Recent Developments and Plans
11.2 Amgen, Inc.
11.2.1 Amgen, Inc. Company Profile
11.2.2 Oncology Drugs Product Overview
11.2.3 Amgen, Inc. Oncology Drugs Market Performance (2019-2024)
11.2.4 Amgen, Inc. Business Overview
11.2.5 Recent Developments and Plans
11.3 Astellas Pharma, Inc.
11.3.1 Astellas Pharma, Inc. Company Profile
11.3.2 Oncology Drugs Product Overview
11.3.3 Astellas Pharma, Inc. Oncology Drugs Market Performance (2019-2024)
11.3.4 Astellas Pharma, Inc. Business Overview
11.3.5 Recent Developments and Plans
11.4 AstraZeneca PLC
11.4.1 AstraZeneca PLC Company Profile
11.4.2 Oncology Drugs Product Overview
11.4.3 AstraZeneca PLC Oncology Drugs Market Performance (2019-2024)
11.4.4 AstraZeneca PLC Business Overview
11.4.5 Recent Developments and Plans
11.5 Bristol Myers Squibb Company
11.5.1 Bristol Myers Squibb Company Company Profile
11.5.2 Oncology Drugs Product Overview
11.5.3 Bristol Myers Squibb Company Oncology Drugs Market Performance (2019-2024)
11.5.4 Bristol Myers Squibb Company Business Overview
11.5.5 Recent Developments and Plans
11.6 F.Hoffmann-La Roche Ltd.
11.6.1 F.Hoffmann-La Roche Ltd. Company Profile
11.6.2 Oncology Drugs Product Overview
11.6.3 F.Hoffmann-La Roche Ltd. Oncology Drugs Market Performance (2019-2024)
11.6.4 F.Hoffmann-La Roche Ltd. Business Overview
11.6.5 Recent Developments and Plans
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Profile
11.7.2 Oncology Drugs Product Overview
11.7.3 Johnson & Johnson Oncology Drugs Market Performance (2019-2024)
11.7.4 Johnson & Johnson Business Overview
11.7.5 Recent Developments and Plans
11.8 Novartis AG
11.8.1 Novartis AG Company Profile
11.8.2 Oncology Drugs Product Overview
11.8.3 Novartis AG Oncology Drugs Market Performance (2019-2024)
11.8.4 Novartis AG Business Overview
11.8.5 Recent Developments and Plans
11.9 Merck & Co., Inc.
11.9.1 Merck & Co., Inc. Company Profile
11.9.2 Oncology Drugs Product Overview
11.9.3 Merck & Co., Inc. Oncology Drugs Market Performance (2019-2024)
11.9.4 Merck & Co., Inc. Business Overview
11.9.5 Recent Developments and Plans
11.10 Pfizer Inc.
11.10.1 Pfizer Inc. Company Profile
11.10.2 Oncology Drugs Product Overview
11.10.3 Pfizer Inc. Oncology Drugs Market Performance (2019-2024)
11.10.4 Pfizer Inc. Business Overview
11.10.5 Recent Developments and Plans
12 Oncology Drugs Manufacturing Cost Analysis
12.1 Oncology Drugs Key Raw Materials Analysis
12.1.1 Key Raw Materials
12.1.2 Price Trend of Key Raw Materials
12.1.3 Key Suppliers of Raw Materials
12.2 Proportion of Manufacturing Cost Structure
12.2.1 Raw Materials
12.2.2 Labor Cost
12.2.3 Manufacturing Expenses
12.3 Manufacturing Process Analysis of Oncology Drugs
12.4 Oncology Drugs Industrial Chain Analysis
13 Market Channel, Distributors, Traders and Dealers
13.1 Market Channel Status
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Oncology Drugs Typical Distributors
13.3 Oncology Drugs Typical Customers
14 Global Oncology Drugs Forecast Market Insights by Type
14.1 Global Oncology Drugs Revenue Market Forecast by Type (2024-2030)
14.2 Global Oncology Drugs Sales Market Forecast by Type (2024-2030)
15 Global Oncology Drugs Forecast Market Insights by Application
15.1 Oncology Drugs Revenue Market Forecast by Application (2024-2030)
15.2 Oncology Drugs Sales Market Forecast by Application (2024-2030)
16 Global Market Growth Forecast Insights
16.1 Global Oncology Drugs Forecast Market Size (2024-2030)
16.2 Oncology Drugs Growth Forecast Insights by Regions
16.2.1 Oncology Drugs Revenue Forecast Market Size by Regions (2024-2030)
16.2.2 Oncology Drugs Sales Forecast Market Size by Regions (2024-2030)
16.2.3 North America Oncology Drugs Forecast Market Size (2024-2030)
16.2.4 Europe Oncology Drugs Forecast Market Size (2024-2030)
16.2.5 Asia-Pacific Oncology Drugs Forecast Market Size (2024-2030)
16.2.6 Latin America Oncology Drugs Forecast Market Size (2024-2030)
16.2.7 Middle East & Africa Oncology Drugs Forecast Market Size (2024-2030)
17 Research Findings and Conclusion
18 Methodology and Data Source
18.1 A Methodology
18.1.1 Research Process
18.1.2 Market Size Estimation
18.1.3 Market Breakdown and Data Triangulation
18.2 B Data Source
18.2.1 Legal Disclaimer
List of Tables and Figures
Figure Oncology Drugs Picture
Table Product Definition of Oncology Drugs
Table Global Oncology Drugs Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
Table Global Oncology Drugs Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
Figure Years Considered
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Oncology Drugs Production by Players (2019-2024)
Table Global Oncology Drugs Production Market Share by Players (2019-2024)
Figure Top 5 Largest Players of Oncology Drugs in 2024
Figure Top 10 Largest Players of Oncology Drugs in 2024
Table Global Oncology Drugs Revenue by Players (2019-2024)
Table Global Oncology Drugs Revenue Market Share by Players (2019-2024)
Figure Top 5 Largest Players of Oncology Drugs in 2024
Figure Top 10 Largest Players of Oncology Drugs in 2024
Table Global Oncology Drugs Production Price by Players
Table Players Market Concentration Ratio (CR5)
Table Global Oncology Drugs Players Geographical Distribution
Table Mergers & Acquisitions, Expansion Plans
Table Company Profiles
Table AbbVie, Inc. Overview
Table AbbVie, Inc. Production, Price, Value, Gross, Gross Margin 2019-2024
Table AbbVie, Inc. Related Developments
Table Company Profiles
Table Amgen, Inc. Overview
Table Amgen, Inc. Production, Price, Value, Gross, Gross Margin 2019-2024
Table Amgen, Inc. Related Developments
Table Company Profiles
Table Astellas Pharma, Inc. Overview
Table Astellas Pharma, Inc. Production, Price, Value, Gross, Gross Margin 2019-2024
Table Astellas Pharma, Inc. Related Developments
Table Company Profiles
Table AstraZeneca PLC Overview
Table AstraZeneca PLC Production, Price, Value, Gross, Gross Margin 2019-2024
Table AstraZeneca PLC Related Developments
Table Company Profiles
Table Bristol Myers Squibb Company Overview
Table Bristol Myers Squibb Company Production, Price, Value, Gross, Gross Margin 2019-2024
Table Bristol Myers Squibb Company Related Developments
Table Company Profiles
Table F.Hoffmann-La Roche Ltd. Overview
Table F.Hoffmann-La Roche Ltd. Production, Price, Value, Gross, Gross Margin 2019-2024
Table F.Hoffmann-La Roche Ltd. Related Developments
Table Company Profiles
Table Johnson & Johnson Overview
Table Johnson & Johnson Production, Price, Value, Gross, Gross Margin 2019-2024
Table Johnson & Johnson Related Developments
Table Company Profiles
Table Novartis AG Overview
Table Novartis AG Production, Price, Value, Gross, Gross Margin 2019-2024
Table Novartis AG Related Developments
Table Company Profiles
Table Merck & Co., Inc. Overview
Table Merck & Co., Inc. Production, Price, Value, Gross, Gross Margin 2019-2024
Table Merck & Co., Inc. Related Developments
Table Company Profiles
Table Pfizer Inc. Overview
Table Pfizer Inc. Production, Price, Value, Gross, Gross Margin 2019-2024
Table Pfizer Inc. Related Developments
Table Global Oncology Drugs Production by Type (2019-2024)
Table Global Oncology Drugs Production Share by Type (2019-2024)
Table Global Oncology Drugs Forecasted Production by Type (2024-2030)
Table Global Oncology Drugs Forecasted Production Share by Type (2024-2030)
Table Global Oncology Drugs Value by Type (2019-2024)
Table Global Oncology Drugs Value Share by Type (2019-2024)
Table Global Oncology Drugs Forecasted Value by Type (2024-2030)
Table Global Oncology Drugs Forecasted Value Share by Type (2024-2030)
Table Global Oncology Drugs Price by Type (2019-2024)
Table Global Oncology Drugs Price Forecast by Type (2024-2030)
Table Global Oncology Drugs Consumption by Application (2019-2024)
Table Global Oncology Drugs Consumption Share by Application (2019-2024)
Table Global Oncology Drugs Forecasted Consumption by Application (2024-2030)
Table Global Oncology Drugs Forecasted Consumption Share by Application (2024-2030)
Table Global Oncology Drugs Revenue by Application (2019-2024)
Table Global Oncology Drugs Revenue Share by Application (2019-2024)
Table Global Oncology Drugs Forecasted Revenue by Application (2024-2030)
Table Global Oncology Drugs Forecasted Revenue Share by Application (2024-2030)
Table Global Oncology Drugs Price by Application (2019-2024)
Table Global Oncology Drugs Price Forecast by Application (2024-2030)
Figure Global Oncology Drugs Production (2019-2030)
Figure Global Oncology Drugs Value (2019-2030)
Table Global Oncology Drugs Production by Region: 2019 VS 2024 VS 2030
Table Global Oncology Drugs Historic Production by Region (2019-2024)
Table Global Oncology Drugs Historic Production Share by Region (2019-2024)
Table Global Oncology Drugs Historic Value by Region (2019-2024)
Table Global Oncology Drugs Historic Value Share by Region (2019-2024)
Table Global Oncology Drugs Forecasted Production by Region (2024-2030)
Table Global Oncology Drugs Forecasted Production Share by Region (2024-2030)
Table Global Oncology Drugs Forecasted Value by Region (2024-2030)
Table Global Oncology Drugs Forecasted Value Share by Region (2024-2030)
Figure North America Oncology Drugs Production (2019-2030)
Figure North America Oncology Drugs Value (2019-2030)
Table North America Production, Price, Value, Gross, Gross Margin 2019-2024
Table SWOT Analysis
Figure Europe Oncology Drugs Production (2019-2030)
Figure Europe Oncology Drugs Value (2019-2030)
Table Europe Production, Price, Value, Gross, Gross Margin 2019-2024
Table SWOT Analysis
Figure China Oncology Drugs Production (2019-2030)
Figure China Oncology Drugs Value (2019-2030)
Table China Production, Price, Value, Gross, Gross Margin 2019-2024
Table SWOT Analysis
Figure Japan Oncology Drugs Production (2019-2030)
Figure Japan Oncology Drugs Value (2019-2030)
Table Japan Production, Price, Value, Gross, Gross Margin 2019-2024
Table SWOT Analysis
Figure Global Oncology Drugs Sales Estimates and Forecasts 2019-2030
Table Global Oncology Drugs Sales by Region: 2019 VS 2024 VS 2030
Table Global Oncology Drugs Sales by Region (2019-2024)
Table Global Oncology Drugs Sales Share by Region (2019-2024)
Table Global Oncology Drugs Sales by Region (2024-2030)
Table Global Oncology Drugs Sales Share by Region (2024-2030)
Figure North America Oncology Drugs Sales (2019-2030)
Table North America Oncology Drugs Sales by Country (2019-2030)
Table North America Oncology Drugs Sales Share by Country (2019-2030)
Figure United States Oncology Drugs Sales Market Size (2019-2030)
Figure Canada Oncology Drugs Sales Market Size (2019-2030)
Figure Europe Oncology Drugs Sales (2019-2030)
Table Europe Oncology Drugs Sales by Country (2019-2030)
Table Europe Oncology Drugs Sales Share by Country (2019-2030)
Figure Germany Oncology Drugs Sales Market Size (2019-2030)
Figure France Oncology Drugs Sales Market Size (2019-2030)
Figure U.K. Oncology Drugs Sales Market Size (2019-2030)
Figure Italy Oncology Drugs Sales Market Size (2019-2030)
Figure Russia Oncology Drugs Sales Market Size (2019-2030)
Figure Asia-Pacific Oncology Drugs Sales (2019-2030)
Table Asia Pacific Oncology Drugs Sales by Region (2019-2030)
Table Asia Pacific Oncology Drugs Sales Share by Region (2019-2030)
Figure China Oncology Drugs Sales Market Size (2019-2030)
Figure Japan Oncology Drugs Sales Market Size (2019-2030)
Figure South Korea Oncology Drugs Sales Market Size (2019-2030)
Figure India Oncology Drugs Sales Market Size (2019-2030)
Figure Southeast Asia Oncology Drugs Sales Market Size (2019-2030)
Figure Australia Oncology Drugs Sales Market Size (2019-2030)
Figure Latin America Oncology Drugs Sales (2019-2030)
Table Latin America Oncology Drugs Sales by Country (2019-2030)
Table Latin America Oncology Drugs Sales Share by Country (2019-2030)
Figure Mexico Oncology Drugs Sales Market Size (2019-2030)
Figure Brazil Oncology Drugs Sales Market Size (2019-2030)
Figure Middle East & Africa Oncology Drugs Sales (2019-2030)
Table Middle East and Africa Oncology Drugs Sales by Country (2019-2030)
Table Middle East and Africa Oncology Drugs Sales Share by Country (2019-2030)
Figure Turkey Oncology Drugs Sales Market Size (2019-2030)
Figure Saudi Arabia Oncology Drugs Sales Market Size (2019-2030)
Figure U.A.E Oncology Drugs Sales Market Size (2019-2030)
Table Raw Material
Table Raw Materials Key Suppliers
Figure Sales Channels
Table Major Distributors of Oncology Drugs with Contact Information
Table Major Customers of Oncology Drugs with Contact Information
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report